ArticlePatient preference and adherence2019

Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population.

Diana Brixner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.